Author response: Synthesizing artificial devices that redirect cellular information at will
Yuchen Liu,Jianfa Li,Zhicong Chen,Weiren Huang,Zhiming Cai
DOI: https://doi.org/10.7554/elife.31936.045
2017-01-01
Abstract:Article Figures and data Abstract eLife digest Introduction Results Discussion Materials and methods References Decision letter Author response Article and author information Metrics Abstract Natural signaling circuits could be rewired to reprogram cells with pre-determined procedures. However, it is difficult to link cellular signals at will. Here, we describe signal-connectors—a series of RNA devices—that connect one signal to another signal at the translational level. We use them to either repress or enhance the translation of target genes in response to signals. Application of these devices allows us to construct various logic gates and to incorporate feedback loops into gene networks. They have also been used to rewire a native signaling pathway and even to create novel pathways. Furthermore, logical AND gates based on these devices and integration of multiple signals have been used successfully for identification and redirection of the state of cancer cells. Eventually, the malignant phenotypes of cancers have been reversed by rewiring the oncogenic signaling from promoting to suppressing tumorigenesis. We provide a novel platform for redirecting cellular information. https://doi.org/10.7554/eLife.31936.001 eLife digest Cells respond to signals from their surrounding environment. External signals activate a sequence of events inside the cell that can change how it behaves. These events are often called signaling pathways and they typically change the cell’s behavior by changing the activity of its genes. A major objective of the field of genetic engineering is to customize or artificially create new signaling pathways to make cells behave in certain ways. The ability to control a cell’s behavior is likely to have a major impact on human health and medicine. For instance, it may be possible to reprogram signaling events in cancer cells so that they die rather than grow rapidly. Researchers are developing artificial genetic devices to manipulate signaling pathways. Molecules of ribonucleic acid (or RNA) are widely used to design such devices. In nature, RNA molecules are highly versatile: messenger RNA molecules carry genetic information in a form that can be translated into protein, while other RNA molecules fine-tune gene expression and perform a host of other roles. RNA is apt for artificial devices because it can be tailored to detect signals and convert this information into a predictable outcome, such as turning specific genes on or off. In 2016, researchers constructed an RNA device to control the expression of genes in response to particular signals. However, this device was too large to deliver efficiently inside cells. Now, Liu, Li, Chen et al. – including some of the researchers involved the 2016 study – design smaller RNA devices to overcome this limitation. Each new device consists of two RNA components: one that recognizes the signal, and another that recognizes the messenger RNA of a target gene. Together the two components trigger the desired change in gene expression in response to a specific signal. The devices were shown to have multiple uses such as making new connections in a signaling pathway and creating new signaling networks. Furthermore, Liu, Li, Chen et al. engineered one device such that it was able to specifically turn off genes in a particular signaling pathway that allows human bladder cancer cells to divide. By silencing these genes, the cancer cells were less able to grow. These newly developed RNA devices should allow other researchers to customize cellular information and may have future therapeutic applications as well. https://doi.org/10.7554/eLife.31936.002 Introduction A basic ability of living cells is to sense extracellular signals by translating them into changes in regulation of cell signaling genes. They use the natural signaling network to execute complex physiological functions, such as cell survival, behavior and identity. As an interdisciplinary branch of biology, genetic engineering has developed rapidly during recent years with the objective of reconstituting the signaling network of the cell for therapeutic and biotechnological applications. Genetic devices have been used to construct novel signaling circuits such as genetic switches (Gardner et al., 2000; Green et al., 2014), digital logic circuits (Moon et al., 2012; Ausländer et al., 2012; Siuti et al., 2013), rewired signaling pathways (Kiel et al., 2010; Yuan et al., 2012; Flock et al., 2014) and feedback loops (Stricker et al., 2008; Prindle et al., 2014). It proved easy to construct networks between synthetic genes using standardized building blocks (Zhang and Jiang, 2010; Schreiber et al., 2016). By controlling the gene expression, there are both positive and negative gene connections. The key difference between them is that in positive connection, the regulated gene is activated for expression, while in negative connection, the regulated gene is silenced. The native intracellular communication can be rewired using genetic devices that block or redirect signals, but connecting native input-output signals at will remains a challenge. For example, the previously developed trans-acting ligand-responsive RNA regulators (Bayer and Smolke, 2005; Win and Smolke, 2007; Ausländer et al., 2010; Beisel et al., 2011; Chang et al., 2012) can be used to engineer novel connections by inhibiting native gene expression in response to extracellular molecules. The conversion of signals into specific cellular events has been accomplished via inducible or repressible antisense RNAs or miRNAs. However, they can only build negative gene connections and the antisense or RNAi-based regulation often exhibits relative low efficiency. Our group has developed a newly-engineered class of genetically encoded devices–‘CRISPR signal conductors' (Liu et al., 2016)–that can sense and respond to cellular signals of interest and in turn activate/repress transcription of specific endogenous genes through a CRISPR interference or activation mechanism. The advantage of these devices is to construct both negative and positive connections between various selected biomolecules and it is only limited by the availability of functional RNA aptamers. However, they require an additional transgene encoding a large protein (dCas9) which further increases the complexity of the system. From an application point of view, the use of a compact RNA-based device is likely to be much more compatible with the limitations of transgene delivery technology than the use of a rather large protein-coding construct. Regretfully, except for miRNAs and siRNAs, no other RNA-based mechanism has been adapted as a wide-spread tool for controlling native gene expression. In this work, we describe the multiple uses of ‘RNA-based signal connectors’ in mammalian cells to modulate translation of mRNAs transcribed from the native genome and from provided plasmids. This new technology acts at the translational stage, apparently promoting or suppressing recruitment of ribosomes to the target mRNA. Without the requirement for an exogenous protein, these small artificial RNAs can establish both negative and positive linkages between input and output signals at will. The work described here is an improvement on the past design of ‘signal conductors’ and shows that they can be used in multiple different applications. Results Design and construction of RNA-based signal-connectors Previous studies have demonstrated that insertion of an RNA aptamer into the 5ʹ untranslated region (5ʹ-UTR) of the messenger RNA (mRNA) can reduce the rate of translation initiation through blocking ribosome scanning in the presence of ligand (Werstuck and Green, 1998; Blount and Breaker, 2006). We hypothesized that a designed external complementary sequence can be used to hybridize to the target mRNA and to guide RNA aptamers for trans-regulation of cellular mRNA translation when a specific signal is present. To test this, we engineered RNA devices which use the antisense domain (a 20 nt antisense RNA) to recognize the mRNA of interest and the previously developed aptamer domain to control translation (Figure 1A). We used the signal-connector to tether a translational activation domain to enhance translation, or the aptamer domain alone to repress the translation. In principle, these modular devices which we called ‘signal-connectors’, can be designed to control the translation of any target mRNA in response to a signal-molecule of interest (Figure 1B) and thus link desired endogenous signals (input) to specific cellular signals (output) (Figure 1C). Figure 1 Download asset Open asset Design and construction of the signal-connectors for constructing linkages between signaling nodes. (A) Domain composition of a signal-connector. The device uses the antisense domain to recognize the mRNA of a target gene and the aptamer domain to respond to different signals to control the translation of the target gene. (B) Connectors that control the expression of cellular genes in response to specific exogenous signals can be engineered through this modular approach. (C) The signal-connectors can be used to direct the linkages between cellular inputs and outputs. https://doi.org/10.7554/eLife.31936.003 Signal-connectors effectively repress target gene expression To test whether this approach could cause efficient repression of translation initiation (Figure 2A) and elongation (Figure 2B), we designed signal-connectors complementary to 12 different regions of the mRNA sequence of the Renilla luciferase reporter gene, either binding to the 5ʹ-UTR or to the coding sequence (Figure 2C and Supplementary file 1). Each of these signal-connectors contained two segments: a 20 nt antisense RNA sequence designed to be complementary to the targeted mRNA sequence and two theophylline aptamer copies (Jenison et al., 1994). Of these 12 constructs, 11 induced significant decreases in Renilla luciferase expression in the presence of 1000 µM theophylline when they were stably transfected into HEK293 cells expressing Renilla luciferase (Figure 2D). The levels of luciferase activity did not change substantially in cells harboring signal-connectors grown in the absence of theophylline. Nuclear and cytoplasmic fractionation analysis showed that these constructs mainly located in the cytoplasm (Figure 2—figure supplement 1). Figure 2 with 10 supplements see all Download asset Open asset The signal-connectors effectively silence/activate gene expression. (A) Design of the signal-connector to block translation of the targeted gene. The device is designed to bind the 5ʹ-UTR of the targeted mRNA. In the absence of the ligand, scanning of the 40S ribosome subunit proceeds until the AUG start codon is reached and translation is initiated. In the presence of the ligand, the ligand-aptamer complex disturbs ribosome scanning and blocks translation initiation. (B) When the binding occurs on the protein-coding region of target mRNA, it blocks ribosome and translation elongation. (C) Various signal-connectors were designed to target different regions of Renilla luciferase mRNA. (D) Renilla luciferase activity was suppressed by the signal-connectors only in the presence of 1 mM theophylline. Empty pGPU6/GFP/Puro vector as used as mock control. (E) Cells stably transfected with the signal-connectors (R1, R2 and R3) were grown in the presence of 0, 250, 500, 750, or 1000 µM theophylline. Addition of theophylline inhibited in vitro translation of the Renilla luciferase mRNA in a dose-dependent manner. (F) Suppression of Renilla luciferase in HEK293 cells by four different signal-connectors that bind to 100 µM tetracycline. (G) Design of the signal-connector for enhancing translation of a targeted gene. The activation of translation by a signal-connector is due to the activation of formation of initiation factor complexes involving eIF4G. In the absence of theophylline/tetracycline, the antisense domain is unable to bind to the mRNA of its target gene. In the presence of theophylline/tetracycline, the aptamer stem is formed and the antisense domain will bind to its target. (H) Renilla luciferase activity was increased by the signal-connector. (I) Addition of theophylline/tetracycline increased translation of the Renilla luciferase mRNA. Empty pGPU6/GFP/Puro vector as used as mock control. NC, negative control vector with two repeated elements not having targets in the human genome. Reported data are mean ± SD from at least three experiments. https://doi.org/10.7554/eLife.31936.004 In addition, the repression activity seemed to be inversely correlated with the target distance from the 5ʹ cap of mRNA, perhaps indicating that the expression of a target gene could be repressed more effectively at the early stage of translation. We then observed that addition of theophylline inhibited luciferase activity in a dose-dependent fashion (Figure 2E). We speculated that the effects of the signal-connectors should also be affected by the valency of ligands recruited to each mRNA target. To test this possibility, we then introduced one or three theophylline aptamers to the 3ʹ end of signal connectors, constructed stably transfected HEK293 cells, detected the luciferase expression level and compared their effects with those of the 2 × signal connectors (Figure 2—figure supplement 2). Devices with three aptamers produced repression effects on luciferase expression that were little stronger relative to the analogous 2 × devices, perhaps due to saturation effects. Devices containing only one aptamer, however, only induced a very weak reduction in reporter gene expression. We also performed an in vitro translation reaction using the macromolecular components (ribosomes, tRNAs, aminoacyl-tRNA synthetases, initiation, elongation and termination factors), purified ligand (theophylline), in vitro transcribed mRNA of Renilla luciferase, as well as in vitro transcribed RNA ‘signal-connector’ (R1 used in Figure 2C) or the negative controls. The in vitro data suggest that the observed silencing effects for signal-connectors were indeed induced by the ligand-aptamer complex (Figure 2—figure supplement 3), indicating a roadblock mechanism. A simple mathematical model was then used to better understand the relationship between the various input parameters and the output (Figure 2—figure supplement 4). The equation described a dose- or concentration-effect relationship and a maximum effect, which are the key features of many biological phenomena. Based on the predictions of this equation and our observed results, we carried out gene knockdown experiments using designed 2 × signal connectors in the presence of sufficient amounts of ligand. To demonstrate the modularity of this approach, we constructed several other signal-connectors to target the Renilla luciferase or the human vascular endothelial growth factor (VEGF) gene and replaced the theophylline aptamers with tetracycline aptamers (Müller et al., 2006) (Supplementary file 2 and Supplementary file 3). The data on cells stably expressing these devices supported the modularity of the signal-connector to different aptamer domains (Figure 2F and Figure 2—figure supplement 5). As expected, these devices (R13 ~R15 and R17 ~R20) showed efficient silencing effects only in the presence of 100 µM tetracycline. Relative levels of VEGF mRNA did not change obviously between cells harboring the signal-connectors grown in the absence or presence of tetracycline, indicating that the signal-connectors function through translational inhibition rather than by affecting mRNA levels (Figure 2—figure supplement 6). These results demonstrated that the signal-connectors could be used as gene switches to down-regulate the expression of a target gene. Signal-connectors effectively activate target gene expression Using the RNA aptamers (Miyakawa et al., 2006) for eukaryotic translation initiation factor 4G (eIF4G), we then determined whether signal-connectors could also enhance translation of a target gene by promoting the formation of initiation factor complexes (Figure 2G and Supplementary file 4). eIF4G recruits the ribosome 40S subunit and activates mRNA translation (Moore, 2005). We chose the Renilla luciferase gene as the target gene and the results of luciferase reporter assay indicated that the specific signal-connector with two eIF4G aptamers induced a 15-fold increase in activity of luciferase protein relative to controls when they were stably transfected into HEK293 cells (Figure 2H). Elimination of one aptamer copy from the construct dramatically decreased the induced activation efficiency, whereas the fold change value increased minimally with the addition of another copy of aptamer (Figure 2—figure supplement 7). Nuclear and cytoplasmic fractionation analysis also showed that this construct mainly located in the cytoplasm (Figure 2—figure supplement 1). We also performed an in vitro translation reaction using the macromolecular components (ribosomes, tRNAs, aminoacyl-tRNA synthetases, initiation, elongation and termination factors except for eIF4G), the purified eIF4G protein, in vitro transcribed uncapped mRNA of Renilla luciferase (the ORF encoding Rluc was placed downstream of a primary ORF), as well as in vitro transcribed RNA ‘signal-connector’ or the negative controls. The data suggest that the observed activating effects for signal-connectors were indeed induced by the eIF4G-aptamer complex (Figure 2—figure supplement 8), indicating a recruitment mechanism. We also constructed a simple mathematical model to clarify the relationship between the various input parameters and the output and the equation revealed that the relationship is nonlinear and saturable (Figure 2—figure supplement 9). Based on the predictions of the new equation for gene activation and the observed results, we carried out gene activation experiments with designed 2× signal connectors in the presence of sufficient amounts of ligand. To achieve dynamic regulation of translation initiation, we used a combination of one aptamer recognizing theophylline or tetracycline and two aptamers recognizing eIF4G to regulate gene expression (Supplementary file 5 and Supplementary file 6), in which the antisense domain was designed to be complementary to the stem sequence of the theophylline(or tetracycline)-binding aptamer (Figure 2G). Theophylline or tetracycline binding stabilizes the aptamer and leads to a conformational change that allows the antisense domain to interfere with the mRNA of the target gene. The results of the luciferase reporter assay on HEK293 cells stably expressing these devices indicated that addition of theophylline or tetracycline increased activity of luciferase (Figure 2I). We also observed a dose-dependent effect (Figure 2—figure supplement 10). These results demonstrated that the signal-connectors could be used as gene switches to up-regulate the expression of a target gene. Construction of all the basic types of logic gates using the signal-connectors In the construction of electronic circuits, logical calculations and digital systems can be practically implemented by using logic gates, including NOT, AND, NAND, OR, NOR, XOR and XNOR gates. Many aspects of information processing by biological cells are similar to signal integration of electronic circuits. We then asked the question whether the signal-connectors could be used to construct complex programmable logic gates and circuits. The excellent gene regulatory ability of the signal-connectors inspired us to construct various logic gates that produced output signals in response to multiple input signals through stably transfecting these devices (Figure 3A). We built all the basic types of two-input Boolean logic gates in HEK293 cells stably expressing the 5’ capped or uncapped Renilla luciferase mRNA construct by using the aptamer recognizing exogenous theophylline or tetracycline signal. In the construct expressing uncapped Renilla luciferase mRNA, an open-reading frame (ORF) encoding Renilla luciferase was placed downstream of a primary ORF. The primary ORF contained a stop codon at the end. Figure 3 Download asset Open asset Logic gates based on signal integration were constructed by the signal-connectors. (A) In each logic gate, the signal-connector integrates the input signals theophylline and tetracycline and produces a luciferase output. Construction of gates that perform NOT (B), AND (C), NAND (D), OR (E), NOR (F), XOR (G) and XNOR (H) functions using the signal-connectors. https://doi.org/10.7554/eLife.31936.015 First, we constructed two NOT gates, each of which produced an inverted version of the input at its output. As suggested in Figure 2D and F, the location of the antisense RNA target sequence along the mRNA was important for inhibition efficiency of the signal-connector. We used two devices (R1 and R13) that maximally suppressed translation of 5ʹ capped Renilla luciferase mRNA in the presence of 1000 µM theophylline or 100 µM tetracycline to build these gates. As shown in Figure 3B, each NOT gate exhibited high luciferase output only in the absence of input signal. We then constructed an AND gate that produced high output only if both input signals were high. As shown in Figure 2—figure supplement 10 and Figure 2I, activation was also inversely correlated with the target distance from the 5ʹ end of the mRNA. We used two signal-connectors (R25 and R29) that minimally activated translation of 5ʹ uncapped Renilla luciferase mRNA in the presence of ligand to build this gate. As shown in Figure 3C, although introduction of each individual signal (1000 µM theophylline or 100 µM tetracycline) did not significantly stimulate expression of the target luciferase gene, the two devices acted synergistically to induce robust translational activation in the presence of both the input signals. We also constructed a NAND gate that exhibited high output if any of the inputs were low. We used two signal-connectors (R12 and R16) that minimally suppressed translation of 5ʹ capped Renilla luciferase mRNA in the presence of ligand to build this gate. As shown in Figure 3D, although introduction of either individual signal (1,000 µM theophylline or 100 µM tetracycline) did not significantly inhibit expression of the target luciferase gene, the two devices acted synergistically to induce robust translational repression in the presence of both input signals. Next, we constructed an OR gate that gave a high output if one or both of its inputs were high. In the building of this gate, we also used two signal-connectors (R22 and R26), each of which strongly activated translation of 5ʹ uncapped Renilla luciferase mRNA in the presence of ligand. As shown in Figure 3E, the luciferase could be produced by either of the two signals (1000 µM theophylline and 100 µM tetracycline). For our next test we constructed a NOR gate which was equivalent to an OR gate followed by a NOT gate. We used two devices (R1 and R13) that maximally inhibited translation of 5ʹ capped Renilla luciferase mRNA in the presence of ligand to build this gate. Since introduction of individual signal significantly suppressed expression of the target gene, the luciferase could be produced only when both of the two signals (1000 µM theophylline and 100 µM tetracycline) were absent (Figure 3F). We also constructed an XOR gate that exhibited high output if either, but not both, of its two inputs were high. We designed signal-connectors (R22 and R27) to target two different regions of the 5ʹ uncapped Renilla luciferase mRNA, which were complementary in their RNA sequence. The results showed that each one of the devices strongly activated expression of luciferase in the presence of corresponding ligand. In contrast, introduction of both devices did not significantly activate expression of the target luciferase gene due to the specific base pairing between their antisense domains (Figure 3G). Finally, we constructed an XNOR gate that exhibited a low output if either, but not both, of its two inputs were high. Using similar design strategies, we used two devices (R1 and R14) that strongly repressed translation of 5ʹ capped Renilla luciferase mRNA in the presence of corresponding ligand. The XNOR gate could have a high luciferase output when both 1000 µM theophylline and 100 µM tetracycline were present or absent (Figure 3H). These results indicated that the signal-connectors could logically link input signals to a desired cellular output signal. Signal-connectors effectively rewire signaling pathways and create feedback loops In eukaryotic cells, signaling proteins often activate transcription factors to initiate transcription of downstream genes. Because in theory the signal-connectors can link transcription factors to suppression of downstream gene translation, we set out to develop modifiers of a molecular network to rewire the native signaling pathway (Figure 4A). β-catenin is a multifunctional protein and usually accumulates in the nucleus of cancer cells, where it activates the transcription of the oncogenic c-Myc gene (He et al., 1998). We synthesized a signal-connector containing β-catenin aptamers (Culler et al., 2010) to target the region within the 5ʹ-UTR of c-Myc mRNA (Supplementary file 7). We investigated the effect of stimulating the β-catenin pathway with leukotriene D4 (LTD4) on the HEK-293 cells stably expressing either the signal-connector or the negative control. Both cell lines exhibited increased expression of c-Myc mRNA (Figure 4B), whereas the cells stably expressing the signal-connector showed a strong decrease in expression of c-Myc protein compared with the cells transfected with negative control (Figure 4C and Figure 4—figure supplement 1). These results demonstrated that our signal-connector could effectively rewire the signaling pathway by establishing a negative connection between the transcription factor and the mRNA of a downstream gene. Figure 4 with 1 supplement see all Download asset Open asset The signal-connectors effectively rewire and create signaling pathways and feedback loops. (A) Mechanisms of the signal-connectors designed to rewire the signaling pathway. (B) The relative expression levels of c-Myc mRNA were evaluated using real-time qPCR in HEK293 cells. The level of c-Myc mRNA was increased in cells that respond to LTD4 stimulation. (C) Histogram of c-Myc. The values were normalized to GAPDH for each sample. The negative control was defined as 1.0. (D) Mechanisms of the signal-connectors designed to create the signaling pathway. (E) Design of the signal-connector that responds to β-catenin. This device frees the antisense region and targets the mRNA only in the presence of β-catenin. (F) The activity of Renilla luciferase was evaluated in HEK293 cells that respond to LTD4 stimulation. (G) Designed models and experimental results illustrating the putative roles of the signal-connectors in constructing the OPN–VEGF positive feedback loop. (H) Designed models and experimental results illustrating the putative roles of the signal-connectors in constructing the OPN–VEGF negative feedback loop. NC, negative control vector with two repeated elements not having targets in the human genome. Reported values are presented as mean ± SD and the experiments were repeated at least three times. https://doi.org/10.7554/eLife.31936.016 We also tested whether the signal-connector could create a novel signaling pathway by linking a regulatory factor to the activation of translation of a selected downstream gene (Figure 4D). The specific signal-connector used one aptamer domain to recognize β-catenin signal and the other two aptamer domains to form the initiation factor complexes. In the absence of β-catenin signal, the antisense domain was sequestered by the stem of the β-catenin aptamer. In the presence of β-catenin signal, this signal-connector could interact with the target Renilla luciferase mRNA (Figure 4E and Supplementary file 8). The effect of leukotriene D4 (LTD4) was investigated by stably transfecting HEK-293 cells with either the signal-connector or the negative control. The results of luciferase assay indicated that the activity of Renilla luciferase in cells expressing the signal-connector was obviously elevated by LTD treatment (Figure 4F), while its activity was not affected by LTD in cells expressing the negative control. These results demonstrated that β-catenin signal could effectively activate the expression of Renilla luciferase with the help of the designed signal-connector. Next, we tested the ability of the signal-connectors to incorporate feedback loops into the gene–gene interaction networks. Positive feedback loops can amplify the cellular signal received from the sender and move a system away from its initial state. We engineered a feedback loop using the signal-connectors in which osteopontin (OPN) and VEGF were each other’s activators (Figure 4G). OPN and VEGF are secreted proteins with cytokine properties and regulate cell motility and angiogenesis (Ferrara et al., 2003; Lyle et al., 2014) and their RNA aptamers were reported in previous literatures (Ng et al., 2006; Mi et al., 2009). We inserted two copies of eIF4G aptamer into the 3’end of OPN or VEGF riboswitch to construct signal-connector recognizing VEGF or OPN. The results of our over-expression experiments revealed that OPN and VEGF were mutually independently operated in bladder cancer T24 cells stably transfected with the negative control device. We transfected the plasm